Ming Li

机构：Tongji University, Wuhan University, Xi’an University, Xi'an University of Technology, Shanghai Tenth People's Hospital, Renmin Hospital of Wuhan University · ORCID：0000-0002-1486-9896

发表论文 63 篇 · 总被引 666 次 · h-index 13

代表论文

• Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells (2021 · Journal of Medicinal Chemistry · 被引 53)
• FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression (2023 · Journal of Experimental & Clinical Cancer Research · 被引 43)
• Overexpression of FES might inhibit cell proliferation, migration, and invasion of osteosarcoma cells (2020 · Cancer Cell International · 被引 24)
• Enhanced cycling stability of F-doped Na4Fe3(PO4)2P2O7 cathode material for sodium-ion batteries (2025 · Journal of Power Sources · 被引 22)
• Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200 (2020 · Journal of Thrombosis and Haemostasis · 被引 18)
• Activating transcription factor 4 aggravates angiotensin II-induced cell dysfunction in human vascular aortic smooth muscle cells via transcriptionally activating fibroblast growth factor 21 (2022 · Korean Journal of Physiology and Pharmacology · 被引 9)